Soaring Penny Stock Alert: OpGen (NASDAQ: OPGN)

One of the rising penny stocks from the healthcare field OpGen (NASDAQ: OPGN) surges more than 60% in premarket as Curetis testing kit for SARS-COV-2 receives certification from the EU. Thus, the revenue may pop soon along with earnings, eventually, making the stock soar higher than $10 or $20.

Its EPS soon may lose the ‘minus’ sign in Q3 and Q4 financial results. It is perhaps the right time to buy OPGN for $1000 at least as the earnings seem to increase.

Late jumpers may see that Q4 earnings show good results and together with long term risk-averse investors they will buy OPGN in bulks. This is just an assumption of an average trader. The situation may change against the stock anytime.

Jack Dawkins

Finance and Tech Contributor